Both in Pharmaceuticals
Oncolytics Biotech vs Rein Therapeutics
Over the past year ONCY returned −62.7% and RNTX returned −61.5%; their daily moves had a correlation of 0.11.
ONCY −62.7% RNTX −61.5%Growth of $1, one year, split-adjusted
| Metric | ONCY | RNTX |
|---|---|---|
| Price | $0.4254 | $0.6700 |
| Market cap | $55.8M | $57.8M |
| Today | −0.54% | −7.79% |
| 1 month | −33.7% | −21.4% |
| 6 months | −51.1% | −35.0% |
| Year to date | −51.3% | −42.2% |
| 1 year | −63.6% | −56.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $4.1M | $40.6M |
| Dividend yield | — | — |
| Volatility (60d) | 63.7% | 95.3% |
| Short % of float | 7.4% | 2.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).